IP Library Granted Patent US 7,410,980
Granted Patent B2
US 7,410,980 · App. 10/495,437 · Granted Aug 12, 2008

Crystals of taxane derivative and process for their production

Assignee: Daiichi Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,410,980
App. No.
10/495,437
Granted
Aug 12, 2008
Kind
B2
Abstract

A crystal of (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-acetoxy-2-benzoyloxy-9,10-[(1S)-2-(dimethylamino)ethylidenedioxy]-5,20-epoxy-1-hydroxytax-11-en-13-yl (2R,3S)-3-(tert-butoxycarbonylamino)-3-(3-fluoro-2-pyridyl)-2-hydroxypropionate, which has characteristic peaks at diffraction angles (2θ) of 6.2°, 10.3°, 10.7°, 11.4°, and 12.0° in a powder X-ray diffraction pattern, and a method for preparing the aforementioned crystal, which comprises the step of performing crystallization by using an organic solvent selected from the group consisting of a ketone type solvent, a nitrile type solvent, and a mixture thereof, or a mixture of said organic solvent and water.

Claims (9)

1. A crystal of (1S,2S,3R,4S,5R,8R,9S,10R,13S)-4-acetoxy-2-benzoyloxy-9,10-[(1S)-2-(dimethylamino)ethylidenedioxy]-5,20-epoxy-1-hydroxytax-11-en-13-yl (2R,3S) -3-(tert-butoxycarbonylamino)-3 -(3 -fluoro-2-pyridyl)-2-hydroxypropionate, which has characteristic peaks at diffraction angles (2θ) of 6.2°, 10.3°, 10.7°, 11.4°, and 12.0° in a powder X-ray diffraction pattern.

2. A method for preparing the crystal according to claim 1 , which comprises performing crystallization by using an organic solvent selected from the group consisting of a ketone type solvent, a nitrile type solvent, and a mixture thereof, or a mixture of said organic solvent and water.

3. The method according to claim 2 , wherein the organic solvent is an organic solvent selected from the group consisting of acetone, acetonitrile, and a mixture thereof.

4. The method according to claim 2 , wherein the crystallization is performed by using a mixture of acetone and water or a mixture of acetonitrile and water.

5. The method according to claim 4 , wherein the mixture of acetone and water or the mixture of acetonitrile and water has a water content of 40 to 50% by weight.

6. The method according to claim 2 , which comprises drying the crystals obtained by the crystallization at a temperature of from 30 to 60° C.

7. The method according to claim 3 , which comprises drying the crystals obtained by the crystallization at a temperature of from 30 to 60° C.

8. The method according to claim 4 , which comprises drying the crystals obtained by the crystallization at a temperature of from 30 to 60° C.

9. The method according to claim 5 , which comprises drying the crystals obtained by the crystallization at a temperature of from 30 to 60° C.

Assignments (2)
MERGER Recorded Aug 1, 2017
From: DAIICHI PHARMACEUTICAL CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 043760/0105 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2004
From: UCHIDA, SEISHIRO; TAKAYANAGI, YOSHIHIRO; ONO, MAKOTO
To: DAIICHI PHARMACEUTICAL CO., LTD.
Reel/Frame 015843/0630 →
Priority Claims (1)
JP 2001-363681 · Nov 29, 2001 · national
Continuity (1)
Related Publication 20050070579A1 · Mar 31, 2005